Gainers
- Ceragon Networks Ltd. CRNT shares surged 54.6% to $4.8699. Ceragon Networks is expected to release its Q4 earnings results on Monday, February 8, 2021.
- ObsEva SA OBSV shares jumped 52.7% to $3.8468 after jumping over 19% on Thursday. ObsEva recently provided updates on Yselty clinical development program.
- Charah Solutions, Inc. CHRA shares climbed 43% to $3.875 after the company announced it has been awarded a 12-year ash marketing contract by Dominion Energy for beneficial use of 8.1 million tons of reclaimed ponded coal ash.
- Atlantic Power Corporation AT shares gained 40.7% to $2.9550 as the company agreed to be acquired by I Squared Capital, a leading global infrastructure investor.
- Polar Power, Inc. POLA shares gained 36.2% to $12.00.
- DBV Technologies S.A. DBVT shares climbed 35% to $5.05 after the company issued an update on investigational viaskin peanut for children ages 4-11 years.
- Foresight Autonomous Holdings Ltd. FRSX rose 30.7% to $8.56. Foresight Autonomous’s Eye-Net Mobile subsidiary recently initiated a pilot project with a global Japanese vehicle manufacturer.
- Glory Star New Media Group Holdings Limited GSMG gained 30.6% to $3.54.
- IKONICS Corporation IKNX surged 22.9% to $12.78.
- DPW 13D filing from IKONICS showed a 7.12% stake in the company.
- Pioneer Power Solutions, Inc. PPSI climbed 22% to $6.52.
- BioVie Inc. BIVI surged 20% to $35.87 after B. Riley FBR initiated coverage on the stock with a Buy rating and announced a $47 price target.
- Bionano Genomics, Inc. BNGO climbed 18.7% to $8.25 after jumping over 23% on Thursday. The company regained compliance with Nasdaq minimum bid price listing requirement. The company highlighted, at its Cytogenomics Symposium, users experiences with Saphyr.
- Rekor Systems, Inc. REKR gained 17.8% to $10.49.
- LightPath Technologies, Inc. LPTH surged 16.2% to $4.8822. LightPath Technologies announced a new European sales office.
- Yield10 Bioscience, Inc. YTEN gained 16% to $9.00.
- Burning Rock Biotech Limited BNR gained 15.7% to $31.84 after gaining over 10% on Thursday.
- BlackBerry Limited BB gained 14.5% to $10.43 after the company sold 90 patents linked to smartphone technology to China’s Huawei, according to the U.S. Patent and Trademark Office records cited by Canada’s The Globe and Mail newspaper.
- Boxlight Corporation BOXL surged 13% to $2.3699 after jumping around 15% on Thursday.
- Tufin Software Technologies Ltd. TUFN rose 12.2% to $17.25 after the company raised preliminary Q4 sales guidance. The company also named Raymond Brancato as Chief Revenue Officer.
- Accolade, Inc. ACCD shares rose 10.8% to $52.91 after the company confirmed it will buy telemedicine start-up 2nd.MD.
- Jounce Therapeutics, Inc. JNCE surged 10.4% to $8.57. Jounce Therapeutics recently announced initiation of Phase 1 INNATE study of JTX-8064 monotherapy and PD-1 inhibitor combination therapy in patients with advanced solid tumors.
- Chuy's Holdings, Inc. CHUY gained 9.9% to $33.36 after Stifel upgraded the stock from Hold to Buy and raised its price target from $23 to $40.
Check out these big penny stock gainers and losers
Losers
- Dogness (International) Corporation DOGZ shares dipped 22.5% to $2.09 after jumping 23% on Thursday. Dogness recently said it experienced strong holiday sales.
- Cardiff Oncology, Inc. CRDF fell 21.8% to $15.31. The company presented data that continues to demonstrate the clinical benefit of Onvansertib in KRAS-mutated mCRC and initial findings from expanded access program.
- SOS Limited SOS fell 20.2% to $2.21 after the company reported exercise of warrants for $26.6 million gross proceeds.
- Cyclacel Pharmaceuticals, Inc. CYCC dipped 14.8% to $7.67.
- Poshmark, Inc. POSH dipped 14.8% to $86.47. Poshmark shares climbed around 142% on Thursday as the company priced its IPO at $42 per share.
- Voxeljet AG VJET fell 13.9% to $14.64 after the company reported a roughly €1.451 billion offering of ordinary shares.
- Lexicon Pharmaceuticals, Inc. LXRX tumbled 13.1% to $6.99. Lexicon Pharmaceuticals recently announced it received FDA regulatory feedback that the results of its SOLOIST and SCORED Phase 3 clinical studies can support a new drug application submission.
- Versus Systems Inc. VS dropped 12.8% to $7.20. Versus Systems priced its public offering of 1,280,000 units at a of USD $7.50 per unit.
- Sino-Global Shipping America, Ltd. SINO dipped 12.7% to $2.96 after gaining over 23% on Thursday.
- Progress Software Corp PRGS fell 10.2% to $43.83. Progress Software reported better-than-expected results for its fourth quarter, but issued weak forecast for the current quarter.
- GrafTech International Ltd. EAF fell 8.7% to $10.60 after the company reported a secondary offering of common stock of 20 million shares.
- 3D Systems Corporation DDD shares fell 8.5% to $29.28 after jumping 36% on Thursday. 3D Systems recently issued strong Q4guidance.
- AirNet Technology Inc. ANTE shares fell 6.5% to $2.43 after gaining 7% on Thursday. The company, last week, entered into investment agreement with Unistar Group Holdings Ltd.
ANTEAirNet Technology Inc
$0.4000-0.02%
BBBlackBerry Ltd
$3.7024.2%
BIVIBioVie Inc
$1.94-6.73%
BNGOBionano Genomics Inc
$0.20190.70%
BNRBurning Rock Biotech Ltd
$6.8411.2%
BOXLBoxlight Corp
$0.3447-3.98%
CRDFCardiff Oncology Inc
$4.31-4.01%
CRNTCeragon Networks Ltd
$4.453.49%
CYCCCyclacel Pharmaceuticals Inc
$0.33300.60%
DBVTDBV Technologies SA
$3.03-0.66%
DDD3D Systems Corp
$3.570.56%
DOGZDogness (International) Corp
$44.65-1.54%
EAFGrafTech International Ltd
$1.59-7.02%
FRSXForesight Autonomous Holdings Ltd
$1.1929.4%
LPTHLightPath Technologies Inc
$2.631.15%
LXRXLexicon Pharmaceuticals Inc
$0.6420-11.3%
POLAPolar Power Inc
$3.053.74%
PPSIPioneer Power Solutions Inc
$4.243.67%
PRGSProgress Software Corp
$66.380.70%
REKRRekor Systems Inc
$0.83002.60%
SOSSOS Ltd
$7.293.99%
VSVersus Systems Inc
$2.1919.0%
YTENYield10 Bioscience Inc
$0.3501-%
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted In:
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in